Diagnostic Study of Patients With Aggressive Non-Hodgkin’s Lymphoma
Study Information
Alliance Study ID: CALGB-9764
NCT Study ID (ClinicalTrials.gov): NCT00003863
Alliance Committee: Lymphoma
Disease or Cancer Type: Lymphoma
Alliance Study Chair: Raju Chaganti, PhD
Status: COMPLETED
Study Description
RATIONALE: Determination of genetic markers for aggressive non-Hodgkin’s lymphoma may help identify patients with this disease and help predict the outcome of treatment.
PURPOSE: Diagnostic study to determine the genetic markers in patients who have aggressive non-Hodgkin’s lymphoma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information